Search all trials

Find therapies in clinical trials near you – page 10

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Psoriatic arthropathy

Not recruiting

Registered drug

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Tildrakizumab

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Secukinumab

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drug

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Hormone-dependent prostate cancer

Not recruiting

Registered drug

Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Registered drug

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Not Used Anti-TNF Therapy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Tildrakizumab

Contact Research Centre

Dry eye+1

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Ianalumab

Contact Research Centre

Psoriatic arthropathy

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bimekizumab

Contact Research Centre

Primary biliary cholangitis

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Seladelpar

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Not recruiting

Registered drugNo placebo

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Azathioprine

Contact Research Centre

Find therapies in clinical trials near you – page 10

137 trials match your criteria

Psoriatic arthropathy

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

Bladder cancer

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Systemic lupus erythematosus

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Hormone-dependent prostate cancer

Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Psoriatic arthropathy

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Not Used Anti-TNF Therapy

Dry eye+1

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Psoriatic arthropathy

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

Primary biliary cholangitis

Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

Bladder cancer

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Chronic lymphocytic leukaemia

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.